What does a positive Tissue Transglutaminase (TTG) Immunoglobulin A (IgA) test result indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What TTG IgA Tells You

A positive TTG IgA test indicates active celiac disease with high diagnostic accuracy, serving as the preferred first-line screening test with 90.7% sensitivity and 87.4% specificity in adults. 1

Primary Diagnostic Significance

  • TTG IgA is the gold standard initial screening test for celiac disease, recommended by the American Gastroenterological Association as the preferred first-line serologic marker 1
  • The test detects IgA antibodies against tissue transglutaminase, the main autoantigen in celiac disease, with sensitivity of 90-96% in adults and 97.7% in children 1, 2
  • A TTG IgA level >10 times the upper limit of normal has >98% positive predictive value for celiac disease and correlates strongly with severe intestinal villous atrophy 1
  • Strongly positive results (≥100 units) occur almost exclusively with Marsh 3 histopathology (villous atrophy) in 96% of cases 3

Critical Testing Requirements

  • The patient MUST be consuming at least 10g of gluten daily for 6-8 weeks before testing to avoid false-negative results 1
  • Total IgA levels must be measured simultaneously because selective IgA deficiency occurs in 1-3% of celiac patients and causes falsely negative TTG IgA results 1, 4
  • If IgA deficiency is present, IgG-based tests (particularly IgG deamidated gliadin peptide with 93.6% sensitivity and 99.4% specificity) should be used instead 1

Test Performance in Real-World Practice

  • At the 15 U/mL threshold in adults: sensitivity 90.7%, specificity 87.4% 5
  • At the 20 U/mL threshold in children: sensitivity 97.7%, specificity 70.2% 5
  • The test performs better at ruling OUT celiac disease than ruling it IN due to lower specificity than sensitivity 1
  • In a hypothetical cohort of 10,000 adults tested, approximately 19 patients with actual celiac disease would have false-negative results 1

Confirmatory Testing Strategy

  • Positive TTG IgA should be confirmed with endomysial antibody (EMA) testing, which has superior specificity of 99.6% in adults and 93.8% in children 5, 1
  • The combination of positive TTG IgA and positive EMA has virtually 100% positive predictive value for celiac disease 1
  • Upper endoscopy with at least 6 duodenal biopsies from the second part of the duodenum remains the gold standard for definitive diagnosis before starting treatment 1

Monitoring Treatment Response

  • TTG IgA levels should be rechecked at 6 months after starting a gluten-free diet, again at 12 months, then annually to assess treatment adherence 1, 2
  • Antibody levels typically decline within months of starting a gluten-free diet, with most significant drops in the first year 1
  • Persistently elevated TTG IgA despite dietary treatment indicates ongoing gluten exposure or poor dietary compliance 1, 2
  • Different TTG IgA assays have varying sensitivity for detecting suboptimal treatment response—chemiluminescence assays appear more sensitive than fluorochrome-enzyme assays in detecting residual intestinal damage 6

Common Pitfalls to Avoid

  • Never start a gluten-free diet before completing the diagnostic workup (serology AND biopsy), as this leads to false-negative results and inconclusive biopsies 1
  • Do not confuse elevated total IgA with celiac disease risk—elevated total IgA actually strengthens confidence in negative TTG IgA results 1
  • False-positive TTG IgA can occur in inflammatory bowel disease, liver disease, and other autoimmune conditions, though typically at lower titers 7
  • Negative TTG IgA does not absolutely exclude celiac disease if the patient was not consuming adequate gluten or has IgA deficiency 1

When Negative TTG IgA Requires Further Investigation

  • If clinical suspicion remains high despite negative serology, proceed directly to upper endoscopy with duodenal biopsies 1
  • Consider HLA-DQ2/DQ8 genetic testing, which has >99% negative predictive value—absence of both alleles essentially rules out celiac disease 1
  • Seronegative celiac disease exists as a subset of patients with characteristic intestinal damage but negative antibody testing 1

References

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnosis and Total IgA Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can you have celiac disease with normal tissue transglutaminase (tTG) Immunoglobulin A (IgA) levels?
Can a tissue transglutaminase (TTG) test be ordered for a patient with suspected celiac disease who is currently avoiding gluten?
What test should be ordered to support the diagnosis of celiac disease in a patient with severe anemia?
What is the significance of a positive Anti-tissue Transglutaminase (Anti-tTGA) Immunoglobulin A (IgA) test result in diagnosing celiac disease?
How are celiac disease Immunoglobulin A (IgA) and Immunoglobulin G (IgG) levels interpreted?
What is the home dose of Eliquis (apixaban) 2.5 mg orally (po) twice daily (bid) after knee surgery?
What is the threshold for Moraxella catarrhalis and human rhinovirus copies in a nasal specimen to be considered pathologic rather than colonization?
What are the treatment options for scleroderma?
What is the best initial diagnostic approach for a patient on a ventilator (vent) with a small pleural effusion and increasing consolidation who is septic, between tranchebronchial aspiration, thoracentesis, or computed tomography (CT) scan?
What is the initial management approach for intermittent urinary incontinence in females?
Is inferior turbinate reduction with ablation and nasal valve collapse remodeling medically indicated for a 61-year-old female with acquired deformity of the nose and hypertrophy of nasal turbinates, who has failed conservative treatments with Flonase (fluticasone), Simply Saline (sodium chloride) nasal mist, and Azelastine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.